AziLsartan treatMent as a swItch strateGy for improvement of uncontrolled Hypertension and blood pressure variabiliTY
Phase of Trial: Phase IV
Latest Information Update: 16 Jan 2015
Price : $35 *
At a glance
- Drugs Azilsartan (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms ALMIGHTY
- 15 Jan 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 18 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 20 Dec 2013 New trial record